Tryptophan-Kynurenine Pathway in COVID-19-Dependent Musculoskeletal Pathology: A Minireview.
Mediators Inflamm
; 2021: 2911578, 2021.
Article
em En
| MEDLINE
| ID: mdl-34621138
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), affecting multiple organ systems, including the respiratory tract and lungs. Several studies have reported that the tryptophan-kynurenine pathway is altered in COVID-19 patients. The tryptophan-kynurenine pathway plays a vital role in regulating inflammation, metabolism, immune responses, and musculoskeletal system biology. In this minireview, we surmise the effects of the kynurenine pathway in COVID-19 patients and how this pathway might impact muscle and bone biology.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Triptofano
/
Doenças Ósseas
/
SARS-CoV-2
/
COVID-19
/
Cinurenina
/
Doenças Musculares
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article